Return to Issue Details
Evaluation of Soluble Suppression of Tumorigenicity 2(sST2), N-terminal Pro-brain Natriuretic Peptide (NT-pro BNP) and Galectin‒3 (‒3) in Patients with Heart Failure
Download
Download PDF